Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2372775
Max Phase: Preclinical
Molecular Formula: C45H69N13O10
Molecular Weight: 952.13
Molecule Type: Protein
Associated Items:
ID: ALA2372775
Max Phase: Preclinical
Molecular Formula: C45H69N13O10
Molecular Weight: 952.13
Molecule Type: Protein
Associated Items:
Canonical SMILES: CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C1CCCCC1)C(C)C
Standard InChI: InChI=1S/C45H69N13O10/c1-25(2)36(56-38(61)31(53-35(60)23-48-4)12-8-18-50-45(46)47)41(64)54-32(20-27-14-16-30(59)17-15-27)39(62)57-37(28-10-6-5-7-11-28)42(65)55-33(21-29-22-49-24-51-29)43(66)58-19-9-13-34(58)40(63)52-26(3)44(67)68/h14-17,22,24-26,28,31-34,36-37,48,59H,5-13,18-21,23H2,1-4H3,(H,49,51)(H,52,63)(H,53,60)(H,54,64)(H,55,65)(H,56,61)(H,57,62)(H,67,68)(H4,46,47,50)/t26-,31-,32-,33-,34-,36-,37-/m0/s1
Standard InChI Key: PRZKOEKNFZMOFE-HZUZZPORSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 952.13 | Molecular Weight (Monoisotopic): 951.5290 | AlogP: -1.59 | #Rotatable Bonds: 25 |
Polar Surface Area: 357.55 | Molecular Species: ZWITTERION | HBA: 12 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.71 | CX Basic pKa: 10.77 | CX LogP: -3.48 | CX LogD: -4.40 |
Aromatic Rings: 2 | Heavy Atoms: 68 | QED Weighted: 0.03 | Np Likeness Score: 0.05 |
1. Nyéki O, Szalay KS, Kisfaludy L, Kárpáti E, Szporny L, Makara GB, Varga B.. (1987) Synthesis of angiotensin II antagonists with variations in position 5., 30 (10): [PMID:3656348] [10.1021/jm00393a006] |
Source(1):